ALPN insider transaction filings
ALPINE IMMUNE SCIENCES, INC. — 13 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2024-05-20. Screen ALPN transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for ALPN between 2026-06-11 and 2026-09-09. The table below lists the most recent filings on record.
Recent Form 4 filings — ALPINE IMMUNE SCIENCES, INC.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-05-20 | 4 | Hernday Natasha — Director | Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 7,650 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 17,500 (derivative) | EDGAR |
| 2024-05-20 | 4 | Drappa Jorn — Director | Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 17,500 (derivative) | EDGAR |
| 2024-05-20 | 4 | PENG STANFORD L — See Remarks | Disposition to issuer (D): 296,163 · Disposition to issuer (D): 48,000 · Disposition to issuer (D): 42,407 (derivative) · Disposition to issuer (D): 236,623 (derivative) · Disposition to issuer (D): 71,874 (derivative) · Disposition to issuer (D): 50,000 (derivative) · +5 more | EDGAR |
| 2024-05-20 | 4 | FUHS ULRICH MARTIN — Chief Accounting Officer | Disposition to issuer (D): 22,820 · Disposition to issuer (D): 7,300 · Disposition to issuer (D): 52,180 (derivative) · Disposition to issuer (D): 28,700 (derivative) · Disposition to issuer (D): 14,600 (derivative) | EDGAR |
| 2024-05-20 | 4 | DURAND REMY — Chief Business Officer | Disposition to issuer (D): 102,192 · Disposition to issuer (D): 31,200 · Disposition to issuer (D): 2,635 (derivative) · Disposition to issuer (D): 26,922 (derivative) · Disposition to issuer (D): 70,155 (derivative) · Disposition to issuer (D): 112,500 (derivative) · +2 more | EDGAR |
| 2024-05-20 | 4 | Peetz Christopher — Director | Disposition to issuer (D): 1,900 · Disposition to issuer (D): 7,650 (derivative) · Disposition to issuer (D): 7,650 (derivative) · Disposition to issuer (D): 7,650 (derivative) · Disposition to issuer (D): 7,650 (derivative) · Disposition to issuer (D): 10,000 (derivative) · +2 more | EDGAR |
| 2024-05-20 | 4 | Rickey James Paul — See Remarks | Disposition to issuer (D): 26,761 · Disposition to issuer (D): 31,200 · Disposition to issuer (D): 836 (derivative) · Disposition to issuer (D): 137 (derivative) · Disposition to issuer (D): 143 (derivative) · Disposition to issuer (D): 1,214 (derivative) · +4 more | EDGAR |
| 2024-05-20 | 4 | Cui Xiangmin — Director, 10% owner Decheng Capital China Life Sciences USD Fund III, L.P. — 10% owner Decheng Capital Management III (Cayman), LLC — 10% owner Decheng Capital Global Healthcare Fund (Master), LP — 10% owner Decheng Capital Global Healthcare GP, LLC — 10% owner | Code (U): 6,582,380 · Code (U): 1,735,544 · Disposition to issuer (D): 7,650 (derivative) · Disposition to issuer (D): 7,650 (derivative) · Disposition to issuer (D): 7,650 (derivative) · Disposition to issuer (D): 10,000 (derivative) · +2 more | EDGAR |
| 2024-05-20 | 4 | Thompson Peter A. — Director | Code (U): 2,416,181 · Code (U): 264,315 · Disposition to issuer (D): 7,650 (derivative) · Disposition to issuer (D): 7,650 (derivative) · Disposition to issuer (D): 7,650 (derivative) · Disposition to issuer (D): 7,650 (derivative) · +3 more | EDGAR |
| 2024-05-20 | 4 | Topper James N — Director | Code (U): 2,829,347 · Disposition to issuer (D): 7,650 (derivative) · Disposition to issuer (D): 7,650 (derivative) · Disposition to issuer (D): 7,650 (derivative) · Disposition to issuer (D): 7,650 (derivative) · Disposition to issuer (D): 10,000 (derivative) · +2 more | EDGAR |
| 2024-05-20 | 4 | GOLD MITCHELL — Executive Chairman and CEO, Director | Code (U): 2,627,157 · Disposition to issuer (D): 13,245 · Disposition to issuer (D): 96,000 · Disposition to issuer (D): 70,000 (derivative) · Disposition to issuer (D): 247,951 (derivative) · Disposition to issuer (D): 208,916 (derivative) · +6 more | EDGAR |
| 2024-05-20 | 4 | CONWAY ROBERT E — Director | Disposition to issuer (D): 50,000 · Disposition to issuer (D): 2,868 (derivative) · Disposition to issuer (D): 3,075 (derivative) · Disposition to issuer (D): 1,912 (derivative) · Disposition to issuer (D): 7,650 (derivative) · Disposition to issuer (D): 7,650 (derivative) · +5 more | EDGAR |
| 2024-05-20 | 4 | ORBIMED ADVISORS LLC — Director OrbiMed Capital GP VI LLC — Director OrbiMed Genesis GP LLC — Director | Code (U): 2,416,181 · Code (U): 264,315 | EDGAR |
Recent 8-K events — ALPINE IMMUNE SCIENCES, INC.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2024-05-20 | 8-K | 1.02 — Termination of a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ALPN returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →